Good outcomes in babies with in-utero bedaquiline exposure.
暂无分享,去创建一个
[1] T. Reddy,et al. Maternal and Infant Outcomes Among Pregnant Women Treated for Multidrug/Rifampicin-Resistant Tuberculosis in South Africa , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] Alimuddin Zumla,et al. Tuberculosis in children, adolescents, and women. , 2020, The Lancet Respiratory Medicine.
[3] J. Bruchfeld,et al. Increased risk of active tuberculosis during pregnancy and postpartum: a register-based cohort study in Sweden , 2019, European Respiratory Journal.
[4] V. Sintchenko,et al. Community-wide Screening for Tuberculosis in a High-Prevalence Setting. , 2019, The New England journal of medicine.
[5] M. Hughes,et al. Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons , 2019, PLoS medicine.
[6] R. Schinazi,et al. Potential drug–drug interactions between antiretroviral therapy and treatment regimens for multi-drug resistant tuberculosis: Implications for HIV care of MDR-TB co-infected individuals , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[7] M. Kruijshaar,et al. Risk of tuberculosis in pregnancy: a national, primary care-based cohort and self-controlled case series study. , 2012, American journal of respiratory and critical care medicine.
[8] P. Goussard,et al. Nosocomial transmission of Mycobacterium tuberculosis in kangaroo mother care units: a risk in tuberculosis-endemic areas. , 2006 .